Skip to main content

Table 1 Baseline characteristics for both datasets

From: Trends in treatment delays for patients with acute ST-elevation myocardial infarction treated with primary percutaneous coronary intervention

  HUS-STEMI I HUS-STEMI II  
  n = 194 n = 306  
  % % p
Mean age, mean (SD) years 64.8 (12.9) 64.3 (14.0) 0.920
Age > 75 years 23.7 26.1 0.542
Male sex 64.9 69.0 0.352
Diabetes 15.5 19.6 0.240
Current smoker 35.6 39.0 0.449
Hypertension 63.4 53.3 0.026
Dyslipidemia 44.8 41.5 0.462
Renal dysfunction 1.5 4.2 0.094
AMI 18.6 10.8 0.014
Stroke 8.8 6.5 0.354
CABG 4.1 5.2 0.573
PCI 9.8 13.4 0.227
ASA 23.2 26.8 0.367
P2Y12 inhibitor 2.1 3.9 0.250
Warfarin 9.3 8.8 0.863
Anterior infarct 46.8 53.6 0.143
Killip class 2--4 12.4 18.0 0.096
Admission at regular hours 41.5 40.8 0.888
  1. Values are percentages with the exception of age.
  2. AMI, acute myocardial infarction; ASA, acetosalicylic acid; CABG, coronary artery bypass graft; PCI, percutaneous coronary intervention.